title: How could we solve the diagnostic dilemma of doxorubicin toxicity in high-risk patients?
authors.forename: Vedat
authors.initials: V
authors.lastname: Davutoglu
authors.forename: Serdar
authors.initials: S
authors.lastname: Soydinc
authors.forename: Ilyas
authors.initials: I
authors.lastname: Akdemir
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000494:pharmacology; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000009:adverse effects* / Q000494:pharmacology; D006331:Heart Diseases / Q000139:chemically induced* / Q000208:ethnology / Q000517:prevention & control; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin